BioCentury
ARTICLE | Company News

Algorithme, SQI Diagnostics deal

January 28, 2013 8:00 AM UTC

SQI and Algorithme partnered to develop a multiplex proof-of-concept assay targeted at testing immunogenicity of heparin and heparin-based low molecular weight biosimilar compounds using SQI's Ig Ple...